Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeying Feng

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|July 17, 2023
Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patientsLin Hu, Qi Huang, Shiqiong Huang, et al.
Journal of Atherosclerosis and Thrombosis|June 12, 2024
Cardiovascular Adverse Events Associated with Tumor Necrosis Factor-Alpha Inhibitors: A Real-World Pharmacovigilance AnalysisJunlong Ma, Jiangfan Cai, Heng Chen, et al.
Plos One|September 11, 2023
Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patientsLin Hu, Shiqiong Huang, Qi Huang, et al.
International Journal of Surgery (London, England)|December 17, 2025
Association between opioid analgesics and learning disorders: a disproportionality analysis of the FDA adverse event reporting system (FAERS) and EudraVigilance databasesZeying Feng, Qianting Qin, Yingmei Shi, et al.
Journal of Translational Medicine|June 16, 2026
Long-term ovarian function risks associated with combined oral contraceptive administration in polycystic ovary syndrome: multisource data integration and protective mechanisms of metforminJingjing Li, Jiajia Wei, Chong Liu, et al.
Biology Direct|June 23, 2026
PCSK9 inhibitors do not increase cognitive riskDongsheng Ni, Zeying Feng, Dehuan Liang, et al.
Investigational New Drugs|February 22, 2022
A pharmacokinetic study to comparatively evaluate the bioequivalence and safety of a humanized recombinant monoclonal antibody targeting human epidermal growth factor receptor-2 with the reference Herceptin in healthy Chinese subjectsFangfang Ding, Jie Huang, Zeying Feng, et al.
Drug Design, Development and Therapy|June 3, 2024
Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World EvidenceChenxi Ouyang, Changjiang Meng, Fei Li, et al.
Journal of Pregnancy|March 27, 2024
Higher Circulating Lymphocytes and the Incidence of Pre-eclampsia and EclampsiaQiuping Zhao, Rongmei Liu, Hui Chen, et al.
Clinical Drug Investigation|February 7, 2024
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with HyperuricemiaShanshan Nie, Yuhang Zhao, Zeying Feng, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|July 17, 2023
Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patientsLin Hu, Qi Huang, Shiqiong Huang, et al.
Journal of Atherosclerosis and Thrombosis|June 12, 2024
Cardiovascular Adverse Events Associated with Tumor Necrosis Factor-Alpha Inhibitors: A Real-World Pharmacovigilance AnalysisJunlong Ma, Jiangfan Cai, Heng Chen, et al.
Plos One|September 11, 2023
Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patientsLin Hu, Shiqiong Huang, Qi Huang, et al.
International Journal of Surgery (London, England)|December 17, 2025
Association between opioid analgesics and learning disorders: a disproportionality analysis of the FDA adverse event reporting system (FAERS) and EudraVigilance databasesZeying Feng, Qianting Qin, Yingmei Shi, et al.
Journal of Translational Medicine|June 16, 2026
Long-term ovarian function risks associated with combined oral contraceptive administration in polycystic ovary syndrome: multisource data integration and protective mechanisms of metforminJingjing Li, Jiajia Wei, Chong Liu, et al.
Biology Direct|June 23, 2026
PCSK9 inhibitors do not increase cognitive riskDongsheng Ni, Zeying Feng, Dehuan Liang, et al.
Investigational New Drugs|February 22, 2022
A pharmacokinetic study to comparatively evaluate the bioequivalence and safety of a humanized recombinant monoclonal antibody targeting human epidermal growth factor receptor-2 with the reference Herceptin in healthy Chinese subjectsFangfang Ding, Jie Huang, Zeying Feng, et al.
Drug Design, Development and Therapy|June 3, 2024
Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World EvidenceChenxi Ouyang, Changjiang Meng, Fei Li, et al.
Journal of Pregnancy|March 27, 2024
Higher Circulating Lymphocytes and the Incidence of Pre-eclampsia and EclampsiaQiuping Zhao, Rongmei Liu, Hui Chen, et al.
Clinical Drug Investigation|February 7, 2024
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with HyperuricemiaShanshan Nie, Yuhang Zhao, Zeying Feng, et al.
Pageof 2